This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →

Resolved

SANDOZ DICLOFENAC RAPIDE

SANDOZ CANADA INCORPORATED

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of SANDOZ DICLOFENAC RAPIDE in Canada?

A shortage of SANDOZ DICLOFENAC RAPIDE 50MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 8, 2026), but it has not started yet.

Why is SANDOZ DICLOFENAC RAPIDE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will SANDOZ DICLOFENAC RAPIDE be available again?

The manufacturer's estimated resolution date is November 6, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength50MG

Last updated2026-09-02

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02261774

Strength

50MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

DICLOFENAC POTASSIUM

Tier

Unrated

Last Updated

2026-09-02

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

SANDOZ DICLOFENAC RAPIDE has 2 shortage/discontinuation reports on file — this is one of them.

2026-09-08

Anticipated Shortage

Disruption of the manufacture of the drug.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929